Cargando...
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
PURPOSE: Migraine can negatively impact patient functioning and quality of life. Here, we report the effects of galcanezumab (GMB), a humanized monoclonal antibody that binds to calcitonin gene-related peptide, on patient-reported outcome (PRO) measures in migraine. METHODS: CGAJ was a Phase III, ra...
Gardado en:
| Publicado en: | Qual Life Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7886775/ https://ncbi.nlm.nih.gov/pubmed/32944843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11136-020-02632-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|